InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
T+90 hit rate
50%
T+90 mean return
-12.8%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Hazeltine Mark, Chief Executive Officer. Officer active across 1 company, notably EXAGEN INC.. Cumulatively, 8 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €15k. Activity tracked since 17 May 2021. The latest transaction was filed on 2 March 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
3,667 shares0Common StockSEC:0001274737-23-000013:0
100,000 shares0Common StockSEC:0001274737-23-000011:0
5,821 shares@ US$2.692440.6% of flowCommon StockSEC:0001274737-23-000008:0
3,241 shares@ US$7.120.023% mcap96.1% of flowCommon StockSEC:0001274737-22-000018:0
63,500 shares0Common StockSEC:0001274737-22-000010
63,500 shares0Common StockSEC:0001274737-22-000010:0
1,934 shares@ US$0.261.9% of flowCommon StockSEC:0001274737-21-000047
1,934 shares@ US$0.260.0005% mcap1.9% of flowCommon StockSEC:0001274737-21-000047:0
8 of 8 declarations
About Hazeltine Mark
Mark Hazeltine is the Chief Operating Officer at Exagen Inc. He has extensive experience in operational management and corporate strategy. His role allows him to oversee daily operations and ensure process efficiency. Mark is recognized for his leadership and commitment to operational excellence.
